Ledger.Open graph →
SEC Form D · filed December 27, 2016

Therabron Therapeutics, Inc

Offering
$6.0M
Sold
$2.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ROCKVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Vinzenz M. Ploerer · Rockville, MDExec · DirectorTodd M. Brady · Rockville, MDDirectorAprile L. Pilon-Clayton · Rockville, MDExec · DirectorEric M. Richman · Rockville, MDDirectorJeffrey M. Zell · Rockville, MDDirectorBlanche M. Johnson · Rockville, MDDirectorLinda M. Chang · Rockville, MDExecTodd M. Brady · Rockville, MDDirectorAprile L. Pilon-Clayton · Rockville, MDExec · DirectorVinzenz M. Ploerer · Rockville, MDExec · DirectorEric M. Richman · Rockville, MDDirectorJeffrey M. Zell · Rockville, MDDirectorBlanche M. Johnson · Rockville, MDDirectorLinda M. Chang · Rockville, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗